Fresenius Kabi USA LLC – FDA 483, Feb 17, 2025
Fresenius Kabi USA LLC, a sterile drug manufacturer in Melrose Park, IL, received a Form 483 citing significant deficiencies across multiple areas. The observations highlight inadequate investigations into critical product defects like foreign particulates and sterility failures, insufficient validation of visual inspection methods, and widespread failures in aseptic processing controls. Repeated issues with environmental monitoring, aseptic technique, and equipment maintenance indicate a systemic lack of control over sterile drug manufacturing processes.
ID · 99c065c1-e60a-4b69-8464-42ed80d0b1a4
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.